KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Invested Capital (2016 - 2025)

Quest Diagnostics' Invested Capital history spans 17 years, with the latest figure at $12.9 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 1.17% year-over-year to $12.9 billion; the TTM value through Dec 2025 reached $12.9 billion, down 1.17%, while the annual FY2025 figure was $12.9 billion, 1.17% down from the prior year.
  • Invested Capital for Q4 2025 was $12.9 billion at Quest Diagnostics, up from $7.8 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $13.0 billion in Q4 2024 and bottomed at $5.9 billion in Q4 2022.
  • The 5-year median for Invested Capital is $6.8 billion (2021), against an average of $7.6 billion.
  • The largest annual shift saw Invested Capital plummeted 43.17% in 2021 before it surged 86.36% in 2023.
  • A 5-year view of Invested Capital shows it stood at $6.5 billion in 2021, then fell by 8.53% to $5.9 billion in 2022, then soared by 86.36% to $11.1 billion in 2023, then rose by 17.87% to $13.0 billion in 2024, then decreased by 1.17% to $12.9 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Invested Capital are $12.9 billion (Q4 2025), $7.8 billion (Q3 2025), and $7.8 billion (Q2 2025).